搜尋
Apimeds Pharmaceuticals US Inc
APUS添加自選
1.510USD
+0.140+10.22%
收盤 05/15, 16:00（美東）報價延遲15分鐘
18.99M總市值
虧損本益比TTM
查看詳細走勢圖
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
+10.22%
5天
-0.23%
1月
-19.68%
6月
-52.96%
今年開始到現在
-7.93%
1年
-11.18%
TradingKey 股票評分
由於缺少必要的數據，暫時無法對該公司進行評分
Apimeds Pharmaceuticals US Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Apimeds Pharmaceuticals US Inc簡介
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
公司代碼APUS
公司Apimeds Pharmaceuticals US Inc
CEOMenon (Vin)
網址https://www.apimedsus.com/
相關品種
-0.03%
-1.75%
-0.15%
-1.11%
-1.77%
-1.79%
-2.22%
-1.88%
-2.35%
-1.63%
+0.43%
-2.99%
-0.37%
-1.64%
+1.79%
0.00%
-2.05%
-0.15%
-2.77%
+0.41%熱門品種
102.160
+3.297 (+3.33%)
300.230
+2.020 (+0.68%)
225.320
-10.420 (-4.42%)
4538.710
-111.520 (-2.40%)
482.020
-7.101 (-1.45%)
1407.610
+24.890 (+1.80%)
724.660
-51.350 (-6.62%)
396.780
-4.290 (-1.07%)
78106.390
-124.610 (-0.16%)
422.240
-21.060 (-4.75%)
